QI, Y.-B.; LI, X.-T.; SHAO, Q.-Q.; XU, L.; ZHANG, W.-J.; SONG, S.-B.; YAN, Q.-N.; SHI, S.-Y.; HU, R.-B.; MEKKY, A.; ZHANG, C.; MA, J.; XIAO, W.; LI, K.; LIU, T.-T.; FANG, X.-H.; ZHANG, L.-D.; YANG, G.-H.; DING, S.-Z. Vonoprazan-containing Dual and Triple Therapies are Non-inferior to Bismuth-quadruple Therapy for Helicobacter pylori Eradication: A Single-center, Prospective, Open-label, Real-World Study. Journal of Gastrointestinal and Liver Diseases, [S. l.], v. 34, n. 3, p. 295–303, 2025. DOI: 10.15403/jgld-6183. Disponível em: https://jgld.ro/jgld/index.php/jgld/article/view/6183. Acesso em: 14 sep. 2026.